Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices 93339 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

through the Commission’s Electronic 

Document Information System (EDIS, 

https://edis.usitc.gov.) No in-person 

paper-based filings or paper copies of 

any electronic filings will be accepted 

until further notice. Persons with 

questions regarding filing should 

contact the Secretary at EDIS3Help@

usitc.gov. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. appendix 3; or (ii) by U.S. 

Government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: November 20, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–27608 Filed 11–25–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–710–711 and 

731–TA–1673–1674 (Final)] 

2,4-Dichlorophenoxyacetic Acid (2,4– 

D) From China and India; Scheduling 

of the Final Phase of Countervailing 

Duty and Antidumping Duty 

Investigations 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

SUMMARY: The Commission hereby gives 

notice of the scheduling of the final 

phase of antidumping and 

countervailing duty investigation Nos. 

701–TA–710–711 and 731–TA–1673– 

1674 (Final) pursuant to the Tariff Act 

of 1930 (‘‘the Act’’) to determine 

whether an industry in the United 

States is materially injured or 

threatened with material injury, or the 

establishment of an industry in the 

United States is materially retarded, by 

reason of imports of 2,4- 

dichlorophenoxyacetic acid (‘‘2,4-D’’) 

from China and India, provided for in 

subheading 2918.99.20 of the 

Harmonized Tariff Schedule of the 

United States, preliminarily determined 

by the Department of Commerce 

(‘‘Commerce’’) to be subsidized and sold 

at less-than-fair-value. 

DATES: November 14, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Charles Cummings ((202) 708–1666), 

Office of Investigations, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436. 

Hearing-impaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these investigations may be viewed on 

the Commission’s electronic docket 

(EDIS) at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION:

Scope.—For purposes of these 

investigations, Commerce has defined 

the subject merchandise as ‘‘2,4- 

dichlorophenoxyacetic acid (2,4-D) and 

its derivative products, including salt 

and ester forms of 2,4-D. 2,4-D has the 

Chemical Abstracts Service (CAS) 

registry number of 94–75–7 and the 

chemical formula C8H6Cl2O3. 

Salt and ester forms of 2,4-D include 

2,4-D sodium salt (CAS 2702–72–9), 2,4- 

D diethanolamine salt (CAS 5742–19–8), 

2,4-D dimethyl amine salt (CAS 2008– 

39–1), 2,4-D isopropylamine salt (CAS 

5742–17–6), 2,4-D tri-isopropanolamine 

salt (CAS 3234180–3), 2,4-D choline salt 

(CAS 1048373–72–3), 2,4-D butoxyethyl 

ester (CAS 1929–733), 2,4-D 2- 

ethylhexylester (CAS 1928–43–4), and 

2,4-D isopropylester (CAS 94–11–1). All 

2,4-D, as well as the salt and ester forms 

of 2,4-D, is covered by the scope 

irrespective of purity, particle size, or 

physical form. 

The conversion of a 2,4-D salt or ester 

from 2,4-D acid, or the formulation of 

nonsubject merchandise with the 

subject 2,4-D, its salts, and its esters in 

the country of manufacture or in a third 

country does not remove the subject 2,4- 

D, its salts, or its esters from the scope. 

For any such formulations, only the 2,4- 

D, 2,4-D salt, and 2,4-D ester 

components of the mixture is covered 

by the scope of the investigations. 

Formulations of 2,4-D are products that 

are registered for end-use applications 

with the Environmental Protection 

Agency and contain a dispersion agent. 

The country of origin of any 2,4-D 

derivative salt or ester is determined by 

the country in which the underlying 

2,4-D acid is produced. 2,4-D, its salts, 

and its esters are classified under 

Harmonized Tariff Schedule of the 

United States (HTSUS) subheading 

2918.99.2010. Subject merchandise, 

including the abovementioned 

formulations, may also be classified 

under HTSUS 2922.12.0001, 

2921.11.0000, 2921.19.6195, 

2922.19.9690, 3808.93.0500, and 

3808.93.1500. The HTSUS subheadings 

and CAS registry numbers are provided 

for convenience and customs purposes. 

The written description of the scope of 

the investigation is dispositive.’’ 

Background.—The final phase of 

these investigations is being scheduled 

pursuant to sections 705(b) and 731(b) 

of the Tariff Act of 1930 (19 U.S.C. 

1671d(b) and 1673d(b)), as a result of 

affirmative preliminary determinations 

by Commerce that certain benefits 

which constitute subsidies within the 

meaning of § 703 of the Act (19 U.S.C. 

1671b) are being provided to 

manufacturers, producers, or exporters 

in China and India of 2,4-D, and that 

such products are being sold in the 

United States at less than fair value 

within the meaning of § 733 of the Act 

(19 U.S.C. 1673b). The investigations 

were requested in petitions filed on 

March 14, 2024, by Corteva Agriscience 

LLC (Indianapolis, Indiana). 

For further information concerning 

the conduct of this phase of the 

investigations, hearing procedures, and 

rules of general application, consult the 


lotter on DSK11XQN23PROD with NOTICES1
93340 Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A and C (19 CFR part 207). 

Participation in the investigations and 

public service list.—Persons, including 

industrial users of the subject 

merchandise and, if the merchandise is 

sold at the retail level, representative 

consumer organizations, wishing to 

participate in the final phase of these 

investigations as parties must file an 

entry of appearance with the Secretary 

to the Commission, as provided in 

§ 201.11 of the Commission’s rules, no 

later than 21 days prior to the hearing 

date specified in this notice. A party 

that filed a notice of appearance during 

the preliminary phase of the 

investigations need not file an 

additional notice of appearance during 

this final phase. The Secretary will 

maintain a public service list containing 

the names and addresses of all persons, 

or their representatives, who are parties 

to the investigations. 

Please note the Secretary’s Office will 

accept only electronic filings during this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov). No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. 

Limited disclosure of business 

proprietary information (BPI) under an 

administrative protective order (APO) 

and BPI service list.—Pursuant to 

§ 207.7(a) of the Commission’s rules, the 

Secretary will make BPI gathered in the 

final phase of these investigations 

available to authorized applicants under 

the APO issued in the investigations, 

provided that the application is made 

no later than 21 days prior to the 

hearing date specified in this notice. 

Authorized applicants must represent 

interested parties, as defined by 19 

U.S.C. 1677(9), who are parties to the 

investigations. A party granted access to 

BPI in the preliminary phase of the 

investigations need not reapply for such 

access. A separate service list will be 

maintained by the Secretary for those 

parties authorized to receive BPI under 

the APO. 

Staff report.—The prehearing staff 

report in the final phase of these 

investigations will be placed in the 

nonpublic record on March 19, 2025, 

and a public version will be issued 

thereafter, pursuant to § 207.22 of the 

Commission’s rules. 

Hearing.—The Commission will hold 

a hearing in connection with the final 

phase of these investigations beginning 

at 9:30 a.m. on Tuesday, April 1, 2025. 

Requests to appear at the hearing should 

be filed in writing with the Secretary to 

the Commission on or before Thursday, 

March 27, 2025. Any requests to appear 

as a witness via videoconference must 

be included with your request to appear. 

Requests to appear via videoconference 

must include a statement explaining 

why the witness cannot appear in 

person; the Chairman, or other person 

designated to conduct the 

investigations, may in their discretion 

for good cause shown, grant such a 

request. Requests to appear as remote 

witness due to illness or a positive 

COVID–19 test result may be submitted 

by 3:00 p.m. the business day prior to 

the hearing. Further information about 

participation in the hearing will be 

posted on the Commission’s website at 

https://www.usitc.gov/calendarpad/ 

calendar.html. 

A nonparty who has testimony that 

may aid the Commission’s deliberations 

may request permission to present a 

short statement at the hearing. All 

parties and nonparties desiring to 

appear at the hearing and make oral 

presentations should attend a 

prehearing conference, if deemed 

necessary, to be held at 9:30 a.m. on 

Friday, March 28, 2025. Parties shall file 

and serve written testimony and 

presentation slides in connection with 

their presentation at the hearing by no 

later than noon on March 31, 2025. Oral 

testimony and written materials to be 

submitted at the public hearing are 

governed by sections 201.6(b)(2), 

201.13(f), and 207.24 of the 

Commission’s rules. Parties must submit 

any request to present a portion of their 

hearing testimony in camera no later 

than 7 business days prior to the date of 

the hearing. 

Written submissions.—Each party 

who is an interested party shall submit 

a prehearing brief to the Commission. 

Prehearing briefs must conform with the 

provisions of § 207.23 of the 

Commission’s rules; the deadline for 

filing is March 26, 2025. Parties shall 

also file written testimony in connection 

with their presentation at the hearing, 

and posthearing briefs, which must 

conform with the provisions of § 207.25 

of the Commission’s rules. The deadline 

for filing posthearing briefs is April 8, 

2025. In addition, any person who has 

not entered an appearance as a party to 

the investigations may submit a written 

statement of information pertinent to 

the subject of the investigations, 

including statements of support or 

opposition to the petition, on or before 

April 8, 2025. On April 23, 2025, the 

Commission will make available to 

parties all information on which they 

have not had an opportunity to 

comment. Parties may submit final 

comments on this information on or 

before April 25, 2025, but such final 

comments must not contain new factual 

information and must otherwise comply 

with § 207.30 of the Commission’s rules. 

All written submissions must conform 

with the provisions of § 201.8 of the 

Commission’s rules; any submissions 

that contain BPI must also conform with 

the requirements of §§ 201.6, 207.3, and 

207.7 of the Commission’s rules. The 

Commission’s Handbook on Filing 

Procedures, available on the 

Commission’s website at https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

Additional written submissions to the 

Commission, including requests 

pursuant to § 201.12 of the 

Commission’s rules, shall not be 

accepted unless good cause is shown for 

accepting such submissions, or unless 

the submission is pursuant to a specific 

request by a Commissioner or 

Commission staff. 

In accordance with §§ 201.16(c) and 

207.3 of the Commission’s rules, each 

document filed by a party to the 

investigations must be served on all 

other parties to the investigations (as 

identified by either the public or BPI 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Authority: These investigations are 

being conducted under authority of title 

VII of the Tariff Act of 1930; this notice 

is published pursuant to § 207.21 of the 

Commission’s rules. 

By order of the Commission. 

Issued: November 20, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–27687 Filed 11–25–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1456] 

Importer of Controlled Substances 

Application: Experic LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Experic LLC to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 


lotter on DSK11XQN23PROD with NOTICES1